BTIG initiates coverage on Maze Therapeutics with a Buy rating and PT of $30.

Tuesday, Sep 2, 2025 8:18 am ET1min read

BTIG initiates coverage on Maze Therapeutics with a Buy rating and PT of $30.

Comments



Add a public comment...
No comments

No comments yet